Lpl Financial LLC Trinity Biotech PLC Transaction History

Lpl Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$0.98 - $6.15 $16,758 - $105,165	-17,100 Reduced 39.68%	26,000 $25,000
Q3 2022 Nov 14, 2022	SELL	$1.09 - $5.45 $6,158 - $30,792	-5,650 Reduced 11.59%	43,100 $46,000
Q2 2022 Aug 12, 2022	SELL	$0.96 - $1.44 $50,806 - $76,209	-52,923 Reduced 52.05%	48,750 $60,000
Q1 2022 May 16, 2022	SELL	$0.92 - $1.44 $4,876 - $7,632	-5,300 Reduced 4.95%	101,673 $108,000
Q4 2021 Feb 14, 2022	BUY	$1.43 - $2.25 $25,597 - $40,275	17,900 Added 20.1%	106,973 $153,000
Q3 2021 Nov 15, 2021	BUY	$1.82 - $2.94 $52,780 - $85,260	29,000 Added 48.27%	89,073 $192,000
Q2 2021 Aug 13, 2021	BUY	$2.77 - $4.18 $105,121 - $158,631	37,950 Added 171.54%	60,073 $177,000
Q1 2021 May 14, 2021	BUY	$3.26 - $6.64 $72,120 - $146,896	22,123 New	22,123 $83,000

30.2K

Ticker TRIB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 38,107,600
Market Cap $46.5M
Description
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious dis...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.